Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Van Acker

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1997
Extension of a predictive substrate model for human cytochrome P4502D6M J de Groot, G J Bijloo, F A van Acker, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activityF A van Acker, J A Hageman, G R Haenen, et al.
Free Radical Biology & Medicine|June 27, 2001
New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicityF A van Acker, J W Hulshof, G R Haenen, et al.
Chemical Research in Toxicology|October 1, 1996
A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108M J de Groot, N P Vermeulen, J D Kramer, et al.
Biochemical Pharmacology|October 17, 1998
Influence of iron chelation on the antioxidant activity of flavonoidsS A van Acker, G P van Balen, D J van den Berg, et al.
Nephron|January 1, 1997
Clearance ratios of amylase isoenzymes and IgG subclasses: do they reflect glomerular charge selectivity?B Buis, P C Wever, G C Koomen, et al.
Agents and Actions. Supplements|January 1, 1991
4- or 5- (omega-aminoalkyl) thiazoles and derivatives; new selective H2-receptor agonistsJ C Eriks, G J Sterk, E M van der Aar, et al.
International Immunology|June 29, 1999
Molecular and cellular basis of the altered immune response against arsonate in irradiated A/J mice autologously reconstitutedJ Ismaïli, D Razanajaona, A Van Acker, et al.
British Journal of Pharmacology|August 1, 1995
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicityS A van Acker, K Kramer, J A Grimbergen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectorsS A van Acker, K Kramer, E E Voest, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1997
Extension of a predictive substrate model for human cytochrome P4502D6M J de Groot, G J Bijloo, F A van Acker, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis of novel 3,7-substituted-2-(3',4'-dihydroxyphenyl)flavones with improved antioxidant activityF A van Acker, J A Hageman, G R Haenen, et al.
Free Radical Biology & Medicine|June 27, 2001
New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicityF A van Acker, J W Hulshof, G R Haenen, et al.
Chemical Research in Toxicology|October 1, 1996
A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108M J de Groot, N P Vermeulen, J D Kramer, et al.
Biochemical Pharmacology|October 17, 1998
Influence of iron chelation on the antioxidant activity of flavonoidsS A van Acker, G P van Balen, D J van den Berg, et al.
Nephron|January 1, 1997
Clearance ratios of amylase isoenzymes and IgG subclasses: do they reflect glomerular charge selectivity?B Buis, P C Wever, G C Koomen, et al.
Agents and Actions. Supplements|January 1, 1991
4- or 5- (omega-aminoalkyl) thiazoles and derivatives; new selective H2-receptor agonistsJ C Eriks, G J Sterk, E M van der Aar, et al.
International Immunology|June 29, 1999
Molecular and cellular basis of the altered immune response against arsonate in irradiated A/J mice autologously reconstitutedJ Ismaïli, D Razanajaona, A Van Acker, et al.
British Journal of Pharmacology|August 1, 1995
Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicityS A van Acker, K Kramer, J A Grimbergen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectorsS A van Acker, K Kramer, E E Voest, et al.
Pageof 8